Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

[Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance].

Hak E, Knol LM, Wilschut JC, Postma MJ.

Ned Tijdschr Geneeskd. 2010;154:A1188. Dutch.

PMID:
20977784
2.

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ.

Pharmacoeconomics. 1999;16 Suppl 1:33-40. Review.

PMID:
10623374
3.

Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

Burckel E, Ashraf T, de Sousa Filho JP, Forleo Neto E, Guarino H, Yauti C, Barreto F de B, Champion L.

Pharmacoeconomics. 1999 Nov;16(5 Pt 2):563-76.

PMID:
10662481
5.

Influenza vaccine for healthy adult workers: an issue for health authorities or employers?

Garattini L, Koleva D.

Health Policy. 2011 Sep;102(1):89-95. doi: 10.1016/j.healthpol.2010.10.011. Epub 2010 Nov 19.

PMID:
21093952
6.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
7.

Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Brydak L, Roiz J, Faivre P, Reygrobellet C.

Clin Drug Investig. 2012 Feb 1;32(2):73-85. doi: 10.2165/11594030-000000000-00000.

PMID:
22201294
8.

[Cost/effectiveness comparison of the vaccine campaign and reduction of sick leave, after vaccination against influenza among the Clermont-Ferrand University Hospital staff].

Dutheil F, Delaire P, Boudet G, Rouffiac K, Djeriri K, Souweine B, Chamoux A.

Med Mal Infect. 2008 Nov;38(11):567-73. doi: 10.1016/j.medmal.2008.09.019. Epub 2008 Nov 12. French.

PMID:
19008061
9.

Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.

Bos JM, Rümke HC, Welte R, Spanjaard L, van Alphen L, Postma MJ.

Pharmacoeconomics. 2006;24(2):141-53.

PMID:
16460135
10.
11.

French economic evaluations of influenza and influenza vaccination.

Levy E.

Pharmacoeconomics. 1996;9 Suppl 3:62-6.

PMID:
10160489
12.

Economic evaluation of vaccination against influenza in New Zealand.

Scott WG, Scott HM.

Pharmacoeconomics. 1996 Jan;9(1):51-60.

PMID:
10160087
13.

[Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].

Cella MT, Corona G, Tuccillo E, Franco G.

Med Lav. 2005 Nov-Dec;96(6):483-9. Italian.

PMID:
16983973
14.

Cost-effectiveness study on influenza prevention in Hong Kong.

Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ.

Health Policy. 2001 Jun;56(3):215-34.

PMID:
11399347
15.

Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination.

Pradas-Velasco R, Antoñanzas-Villar F, Martínez-Zárate MP.

Pharmacoeconomics. 2008;26(1):45-56.

PMID:
18088158
16.

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

Navas E, Salleras L, Domínguez A, Ibáñez D, Prat A, Sentís J, Garrido P.

Vaccine. 2007 Apr 20;25(16):3233-9. Epub 2007 Jan 25.

PMID:
17324489
17.

The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.

Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR.

Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.

PMID:
18343537
18.

The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan.

Chan AL, Shie HJ, Lee YJ, Lin SJ.

Pharm World Sci. 2008 Jan;30(1):39-43. Epub 2007 Jun 30.

PMID:
17602309
19.

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.

PMID:
16277546
20.

Supplemental Content

Support Center